Litcius/Paper detail

Natural Nanoskin ACT Management of the Rare Disease as Burnt Patient with Epidermolysis Bullosa and Stevens-Johnson

P. Basmaji, Vânia Martins, Mohamed Kanjo

2020Journal of Biomaterials and Nanobiotechnology12 citationsDOIOpen Access PDF

Abstract

Epidermolysis Bullosa (EB) is a group of rare genetic skin conditions, which is characterised by extremely fragile skin and recurrent blister formation, resulting from minor mechanical friction or trauma. Sufferers of EB have compared the sores to third-degree burns. Stevens-Johnson syndrome is a rare but very serious skin problem, which causes the appearance of reddish lesions throughout the body and other changes, such as difficulty in breathing and fever, which can endanger the life of the affected person. The aim of this study was to show efficacy of a NANOSKIN ACT, AND NANOSKIN ACT SOFT wound dressing on the wound care management in patients with EB AND Stevens-Johnson syndrome (SJS).

Topics & Concepts

Epidermolysis bullosaDermatologyMedicineJunctional epidermolysis bullosa (veterinary medicine)BiologyGeneBiochemistryMutationAutoimmune Bullous Skin DiseasesNail Diseases and TreatmentsContact Dermatitis and Allergies
Natural Nanoskin ACT Management of the Rare Disease as Burnt Patient with Epidermolysis Bullosa and Stevens-Johnson | Litcius